// App-Quantinova.ai

P333 : Changing patterns of biological therapy use with the introduction of biosimilars in inflammatory bowel disease

Researchers

Presenter

  • K. Mortier

Principal Investigators

  • I. Arnott

  • R.K. Russell

Medical Centers

  • Royal College of Physicians of London (RCP), London, United Kingdom

  • NHS Lothian - Western General Hospital, Gastrointestinal Unit, Edinburgh, UK

  • Royal Hospital for Children, Department of Paediatric Gastroenterology, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved